To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
The House of Representatives begins debate Wednesday on a bill its supporters say will drastically reduce the cost of 250 of the most expensive medicines on the market.
Purdue Pharma, the maker of OxyContin, declared bankruptcy as part of a tentative deal to settle more than 2,000 lawsuits alleging that they and other opioid manufacturers worsened the US opioid epidemic.
The opioid crisis is not just an American problem; it’s a global one.
Millions of Americans are feeling the pain as life-saving medications soar in price.